Cargando…
Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast.
Platelet sensitivity to prostacyclin (PG12) was determined in normal male and female subjects, and in patients with benign and malignant tumours of the breast. The IC50 overall mean values for PG12 on ADP-induced platelet aggregation were similar for normal men and women, being 0.97 +/- 0.05 ng ml-1...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976827/ https://www.ncbi.nlm.nih.gov/pubmed/3881119 |
_version_ | 1782135135720701952 |
---|---|
author | Benedetto, C. Zonca, M. Tavella, A. M. Petitti, E. Massobrio, M. Nigam, S. Slater, T. F. |
author_facet | Benedetto, C. Zonca, M. Tavella, A. M. Petitti, E. Massobrio, M. Nigam, S. Slater, T. F. |
author_sort | Benedetto, C. |
collection | PubMed |
description | Platelet sensitivity to prostacyclin (PG12) was determined in normal male and female subjects, and in patients with benign and malignant tumours of the breast. The IC50 overall mean values for PG12 on ADP-induced platelet aggregation were similar for normal men and women, being 0.97 +/- 0.05 ng ml-1 and 0.83 +/- 0.07 ng ml-1 respectively. However, there were significant differences in the IC50 values for women in the 1st (0.81 +/- 0.06 ng ml-1) vs. 2nd (1.37 +/- 0.13 ng ml-1) phase of the menstrual cycle; post-menopausal women gave similar values to normal males and to pre-menopausal women in the 1st phase of the cycle. No significant differences were found between normal subjects and patients with benign or malignant tumours of the breast when account was taken of the status of the patient in relation to the phase of the menstrual cycle and the menopause. The importance of the hormonal status in evaluating changes in platelet sensitivity in patients with breast cancer is strongly emphasised. |
format | Text |
id | pubmed-1976827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1985 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19768272009-09-10 Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast. Benedetto, C. Zonca, M. Tavella, A. M. Petitti, E. Massobrio, M. Nigam, S. Slater, T. F. Br J Cancer Research Article Platelet sensitivity to prostacyclin (PG12) was determined in normal male and female subjects, and in patients with benign and malignant tumours of the breast. The IC50 overall mean values for PG12 on ADP-induced platelet aggregation were similar for normal men and women, being 0.97 +/- 0.05 ng ml-1 and 0.83 +/- 0.07 ng ml-1 respectively. However, there were significant differences in the IC50 values for women in the 1st (0.81 +/- 0.06 ng ml-1) vs. 2nd (1.37 +/- 0.13 ng ml-1) phase of the menstrual cycle; post-menopausal women gave similar values to normal males and to pre-menopausal women in the 1st phase of the cycle. No significant differences were found between normal subjects and patients with benign or malignant tumours of the breast when account was taken of the status of the patient in relation to the phase of the menstrual cycle and the menopause. The importance of the hormonal status in evaluating changes in platelet sensitivity in patients with breast cancer is strongly emphasised. Nature Publishing Group 1985-01 /pmc/articles/PMC1976827/ /pubmed/3881119 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Benedetto, C. Zonca, M. Tavella, A. M. Petitti, E. Massobrio, M. Nigam, S. Slater, T. F. Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast. |
title | Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast. |
title_full | Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast. |
title_fullStr | Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast. |
title_full_unstemmed | Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast. |
title_short | Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast. |
title_sort | platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976827/ https://www.ncbi.nlm.nih.gov/pubmed/3881119 |
work_keys_str_mv | AT benedettoc plateletsensitivitytoprostacyclininnormalsubjectsandinpatientswithbenignandmalignanttumoursofthebreast AT zoncam plateletsensitivitytoprostacyclininnormalsubjectsandinpatientswithbenignandmalignanttumoursofthebreast AT tavellaam plateletsensitivitytoprostacyclininnormalsubjectsandinpatientswithbenignandmalignanttumoursofthebreast AT petittie plateletsensitivitytoprostacyclininnormalsubjectsandinpatientswithbenignandmalignanttumoursofthebreast AT massobriom plateletsensitivitytoprostacyclininnormalsubjectsandinpatientswithbenignandmalignanttumoursofthebreast AT nigams plateletsensitivitytoprostacyclininnormalsubjectsandinpatientswithbenignandmalignanttumoursofthebreast AT slatertf plateletsensitivitytoprostacyclininnormalsubjectsandinpatientswithbenignandmalignanttumoursofthebreast |